Biopharmaceuticals Equipment Value Chain: United States and Europe

With the fast-evolving biopharma drug discovery and development, and the many processes involved in it, numerous big and small businesses are joining the industry value chain. The capabilities of these participating businesses vary widely both in terms of their role (innovator, CMO, and CDMO) and in terms of production processes (upstream, downstream, and formulation development). It is crucial to understand the value chain of the industry to identify the market opportunities for excipients, equipment, and services related to them. It is also important to understand value chain capabilities to identify opportunities for strategic partnerships and business integration.

Scope

BIOPHARMA EQUIPMENT MARKET ANALYSIS

• Market size
• Competitive landscape
• Technology trends
• Outlook

BIOPHARMA VALUE CHAIN ASSESSMENT

• Value chain overview
• Capability profiles of key businesses in each stage of the value chain

REPORT

BIOPHARMACEUTICALS INDUSTRY OVERVIEW

EQUIPMENT MARKET ANALYSIS

• Market size by stage of production
• Market size by type of equipment
• Supplier share analysis
• New technologies, drug trends
• Drivers and restraints
• Outlook for five years

BIOPHARMACEUTICALS VALUE CHAIN

• Overview of value chain
• Assessment of different businesses and their roles in the value chain
• Profiles on key businesses across of the value chain (total 15 profiles)
  • - Stages of production
  • - Type of equipment in use
  • - Modalities, drug classes, therapeutic categories

Subscriber Benefits

This report serves as an excellent resource for suppliers of equipment and excipients to identify opportunities with customers. Specifically, it assists subscribers by providing:

• An understanding of the equipment market in the biopharmaceuticals industry
• An insight into the value chain of biopharmaceuticals to identify sales potential
• Identification of growth opportunities for acquiring customers and partners